Disclosure(s): ABIM- CC speciality group: Board Member/Officer/Trustee (Ongoing), Other Financial or Material Support (Ongoing)
Disclosure(s):
Sandra Kane-Gill, MSc, PharmD, FCCP: ABIM- CC speciality group: Board Member/Officer/Trustee (Ongoing), Other Financial or Material Support (Ongoing)
Patients with acute kidney injury are subject to significant discrepancies in metabolism of drugs and steady state of intermittent or continuous infusion medications - this is true even without the use of continuous renal replacement therapy (RRT) for patients with AKI. In this session, we will take a pharmacological approach to optimizing the hourly, routine, and daily approach to medication management and adjudication in critical illness associated with AKI - paying particular attention to antibiotics, vasoactive medications, and sedation.
